The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
Authors
Keywords
-
Journal
Lancet Haematology
Volume 8, Issue 1, Pages e80-e93
Publisher
Elsevier BV
Online
2020-12-23
DOI
10.1016/s2352-3026(20)30365-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP
- (2020) Laetitia Vercellino et al. BLOOD
- The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium
- (2020) Jakoba J Eertink et al. BLOOD
- Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
- (2020) Connie L. Batlevi et al. EUROPEAN JOURNAL OF CANCER
- Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial
- (2020) Heiko Schöder et al. BLOOD
- FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
- (2020) N. George Mikhaeel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA
- (2020) Sarah C. Rutherford et al. Blood Advances
- Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA
- (2020) Steven Le Gouill et al. BLOOD
- Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma
- (2019) Yoshiaki Abe et al. CLINICAL NUCLEAR MEDICINE
- Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma
- (2019) Domenico Albano et al. ANNALS OF NUCLEAR MEDICINE
- Time to prepare for risk adaptation in lymphoma by standardising measurement of metabolic tumour burden
- (2019) Sally F. Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
- (2019) Clément Bailly et al. HAEMATOLOGICA
- RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI.
- (2019) M. Federico et al. HEMATOLOGICAL ONCOLOGY
- Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
- (2019) Christine Schmitz et al. EUROPEAN JOURNAL OF CANCER
- Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
- (2019) Viola Poeschel et al. LANCET
- Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma
- (2018) Luca Ceriani et al. BLOOD
- Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
- (2018) Hajira Ilyas et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Feasibility of state of the art PET/CT systems performance harmonisation
- (2018) Andres Kaalep et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted-EPOCH-R: A paradigm shift in clinical decision making
- (2018) Christopher Melani et al. HAEMATOLOGICA
- Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
- (2018) Ulrich Dührsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
- (2018) Ronald Boellaard et al. JOURNAL OF NUCLEAR MEDICINE
- End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted-EPOCH-R: A paradigm shift in clinical decision making
- (2018) Christopher Melani et al. HAEMATOLOGICA
- Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2018) Coreline N. Burggraaff et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
- (2018) Ho-Young Yhim et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
- (2018) David M. Kurtz et al. JOURNAL OF CLINICAL ONCOLOGY
- Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
- (2018) Jessica L. Brady et al. BLOOD
- Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
- (2018) Judith Trotman et al. LANCET ONCOLOGY
- Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry
- (2018) Ur Metser et al. RADIOLOGY
- FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
- (2017) Sally F. Barrington et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- RADIOTHERAPY TO BULKY DISEASE PET-NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL
- (2017) M. Pfreundschuh et al. HEMATOLOGICAL ONCOLOGY
- Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma
- (2017) Luca Ceriani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
- (2017) Anne-Ségolène Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluating early interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with the SUVmax-liver-based interpretation for predicting the outcome in diffuse large B-cell lymphoma
- (2017) Yang Fan et al. LEUKEMIA & LYMPHOMA
- Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores
- (2017) Jihyun Kim et al. LEUKEMIA & LYMPHOMA
- The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study
- (2016) M. Alzahrani et al. ANNALS OF ONCOLOGY
- Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma
- (2016) A.-S. Cottereau et al. CLINICAL CANCER RESEARCH
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
- (2016) N. George Mikhaeel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- (2016) Mark Hertzberg et al. HAEMATOLOGICA
- Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
- (2016) Michel Meignan et al. JOURNAL OF CLINICAL ONCOLOGY
- ATLAAS: an automatic decision tree-based learning algorithm for advanced image segmentation in positron emission tomography
- (2016) Beatrice Berthon et al. PHYSICS IN MEDICINE AND BIOLOGY
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- (2016) Mark Hertzberg et al. HAEMATOLOGICA
- Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis
- (2015) Mark J. Bishton et al. BRITISH JOURNAL OF HAEMATOLOGY
- Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)
- (2015) Lode J. Swinnen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis
- (2015) Georg Kuhnert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
- (2015) Christoph Mamot et al. JOURNAL OF CLINICAL ONCOLOGY
- Utility of interim and end-of-treatment [18F]-fluorodeoxyglucose positron emission tomography–computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma
- (2015) Scott F. Huntington et al. LEUKEMIA & LYMPHOMA
- The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)
- (2014) S. Luminari et al. ANNALS OF ONCOLOGY
- Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial
- (2014) Emilia Pardal et al. BRITISH JOURNAL OF HAEMATOLOGY
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
- (2014) R. Carr et al. JOURNAL OF NUCLEAR MEDICINE
- Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma
- (2014) J. J. Cerci et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
- (2014) Karen Juul Mylam et al. LEUKEMIA & LYMPHOMA
- Clinical impact of contrast-enhanced computed tomography combined with low-dose18F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management
- (2014) Julia Chalaye et al. LEUKEMIA & LYMPHOMA
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
- (2014) Judith Trotman et al. Lancet Haematology
- The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi
- (2013) S. Luminari et al. ANNALS OF ONCOLOGY
- PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement
- (2013) A. B. Khan et al. BLOOD
- 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
- (2013) Carla Casulo et al. LEUKEMIA & LYMPHOMA
- Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
- (2012) Jehan Dupuis et al. JOURNAL OF CLINICAL ONCOLOGY
- SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
- (2011) R.-O. Casasnovas et al. BLOOD
- Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2011) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma
- (2010) Ludovic Le Dortz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Improvement of Early 18F-FDG PET Interpretation in Diffuse Large B-Cell Lymphoma: Importance of the Reference Background
- (2010) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
- (2009) A. Noy et al. ANNALS OF ONCOLOGY
- Prognostic Value of Interim 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment at 4 Cycles of Chemotherapy
- (2009) E. Itti et al. JOURNAL OF NUCLEAR MEDICINE
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started